XTX Topco Ltd Has $3.63 Million Stake in Encompass Health Corporation $EHC

XTX Topco Ltd raised its stake in shares of Encompass Health Corporation (NYSE:EHC) by 1,288.5% in the 2nd quarter, Holdings Channel reports. The firm owned 29,603 shares of the company’s stock after purchasing an additional 27,471 shares during the quarter. XTX Topco Ltd’s holdings in Encompass Health were worth $3,630,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Belpointe Asset Management LLC bought a new stake in shares of Encompass Health in the 2nd quarter valued at $210,000. Intech Investment Management LLC grew its holdings in Encompass Health by 21.8% during the first quarter. Intech Investment Management LLC now owns 21,329 shares of the company’s stock worth $2,160,000 after buying an additional 3,815 shares in the last quarter. Park Avenue Securities LLC raised its holdings in shares of Encompass Health by 28.5% in the second quarter. Park Avenue Securities LLC now owns 9,153 shares of the company’s stock valued at $1,122,000 after purchasing an additional 2,030 shares during the last quarter. Whalen Wealth Management Inc. bought a new position in shares of Encompass Health during the 2nd quarter worth approximately $644,000. Finally, Bahl & Gaynor Inc. grew its stake in Encompass Health by 14.8% in the 2nd quarter. Bahl & Gaynor Inc. now owns 288,226 shares of the company’s stock valued at $35,345,000 after purchasing an additional 37,161 shares during the period. Institutional investors and hedge funds own 97.25% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently commented on EHC. Bank of America raised their price objective on shares of Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a report on Wednesday, September 10th. Barclays increased their target price on Encompass Health from $141.00 to $150.00 and gave the stock an “overweight” rating in a research report on Thursday, October 30th. Zacks Research lowered Encompass Health from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 19th. UBS Group boosted their price objective on Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Thursday, October 2nd. Finally, Weiss Ratings restated a “buy (b+)” rating on shares of Encompass Health in a research note on Wednesday, October 8th. Two investment analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $142.86.

Encompass Health Stock Up 2.7%

Shares of Encompass Health stock opened at $116.21 on Wednesday. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a 12-month low of $87.85 and a 12-month high of $127.99. The company has a market cap of $11.69 billion, a P/E ratio of 21.97, a PEG ratio of 2.20 and a beta of 0.91. The company’s fifty day simple moving average is $120.96 and its two-hundred day simple moving average is $119.55.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Wednesday, March 16th. The company reported $0.93 earnings per share for the quarter. The business had revenue of $136.30 million for the quarter. Encompass Health had a return on equity of 18.19% and a net margin of 9.33%. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. Research analysts anticipate that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be paid a $0.19 dividend. The ex-dividend date is Friday, January 2nd. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. Encompass Health’s dividend payout ratio is presently 14.37%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.